Lipoamide Attenuates Hypertensive Myocardial Hypertrophy Through PI3K/Akt-Mediated Nrf2 Signaling Pathway
Journal of Cardiovascular Translational Research · 2024
DOI: 10.1007/s12265-024-10488-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2024. Verfasst von Hongjuan Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Medical University, Guiyang, Guizhou Province, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Signal Transduction, Proto-Oncogene Proteins c-akt, Oxidative Stress. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The process of myocardial hypertrophy in hypertension can lead to excessive activation of oxidative stress. Lipoamide (ALM) has significant antioxidant and anti-inflammatory effects. This study aimed to investigate the effects of ALM on hypertension-induced cardiac hypertrophy, as well as explore its underlying mechanisms. We evaluated the effects of ALM on spontaneously hypertensive rats and rat cardiomyocytes treated with Ang II. We found that ALM was not effective in lowering blood pressure in SHR, but it attenuated hypertension-mediated cardiac fibrosis, oxidative stress, inflammation, and hypertrophy in rats. After that, in cultured H9C2 cells stimulated with Ang II, ALM increased the expression of antioxidant proteins that were decreased in the Ang II group. ALM also alleviated cell hypertrophy and the accumulation of ROS, while LY294002 partially abrogated these effects. Collectively, these results demonstrate that ALM could alleviate oxidative stress in cardiac hypertrophy, potentially through the activation of the PI3K/Akt-mediated Nrf2 signaling pathway. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou Medical University, Guiyang, Guizhou Province, China.
- Department of Ultrasound Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.
- Guizhou Medical University, Guiyang, Guizhou Province, China. zhangbei@gmc.edu.cn.
- Department of Ultrasound Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China. zhangbei@gmc.edu.cn.
ORCID-Profile: Bei Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cao, H., Zhao, L., Yuan, Y., Liao, C., Zeng, W., Li, A., Huang, Q., Zhao, Y., Fan, Y., Jiang, L., Song, D., Li, S., & Zhang, B. (2024). Lipoamide Attenuates Hypertensive Myocardial Hypertrophy Through PI3K/Akt-Mediated Nrf2 Signaling Pathway. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-024-10488-9
Vancouver
Cao H, Zhao L, Yuan Y, Liao C, Zeng W, Li A, et al. Lipoamide Attenuates Hypertensive Myocardial Hypertrophy Through PI3K/Akt-Mediated Nrf2 Signaling Pathway. Journal of Cardiovascular Translational Research. 2024. doi:10.1007/s12265-024-10488-9
BibTeX
@article{Cao2024,
author = {Cao, Hongjuan and Zhao, Lina and Yuan, Yao and Liao, Chunyan and Zeng, Weidan and Li, Aiyue and Huang, Quanfeng and Zhao, Yueyao and Fan, Yubing and Jiang, Liu and Song, Dandan and Li, Sha and Zhang, Bei},
title = {Lipoamide Attenuates Hypertensive Myocardial Hypertrophy Through PI3K/Akt-Mediated Nrf2 Signaling Pathway},
journal = {Journal of Cardiovascular Translational Research},
year = {2024},
doi = {10.1007/s12265-024-10488-9}
}
EUVIMED